SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRoebuck Food Regulatory News (RFG)

Share Price Information for Roebuck Food (RFG)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £26.80m
RFG Live PriceLast checked at - London Stock Exchange

Intraday Roebuck Food Share Chart

Interim Results 2024

27 Sep 2024 07:00

RNS Number : 8965F
Roebuck Food Group PLC
27 September 2024
 

 

Roebuck Food Group plc

Interim results 2024

 

Results

 

Roebuck Food Group plc (AIM: RFG) is pleased to announce its interim results for the six months to end June 2024.

 

During this period, management have completed a fundamental strategic review of the business and have developed a new strategic vision for Roebuck Food Group plc. This vision has a number of guiding pillars including the advancement and implementation of climate mitigation technologies, throughout the agricultural supply chain, from primary production through to food consumption. At this juncture, management believe we can build a business of significant scale and size over the next number of years and we are presently evaluating a number of significant investment opportunities.

 

As part of this new strategic vision, management have completed the divestment of two subsidiaries (Town View Foods and Cantwellscourt Farm), which were no longer considered appropriate to the direction management want to take the business. The sale of Town View Foods has results in a significant goodwill write off of circa Stg £2.3m. Net debt stood at £0.1m at end June 2024.

 

Continuing Operations

Moorhead & McGavin, the company which we acquired in December 2023 and which is focussed on the plant based opportunity, is growing strongly. Sales were up 22%, in the first half of the year, compared with the prior year. We continue to invest in people to grow this business and notwithstanding this investment, we expect the business to improve its profitability this year, on 2023 levels.

 

Foro Food Solutions, our Cork based sourcing business comprises two parts; the sourcing business which engages primarily with the food service and food manufacturing segments of the food market and a newer addition, which engages primarily with retail. The legacy division is profitable and growing strongly from a very small base. The latter will need some time to cover its investment in people. This business is benefitting from some synergies with Moorhead & McGavin and vice versa.

Discontinued Operations

The period under review and into the second half of the year has seen the divestment of two of our subsidiaries; Town View Foods (which has resulted in a substantial goodwill write off of £2.3m in the interim figures just published) together with Cantwellscourt Farm ltd.

 

The loss at Cantwellscourt Farm comprises a write down on the asset, professional fees, together with trading losses, reflecting the time of the year when the acquisition was completed (dairy farms typically lose money in the first few months of the year). The losses at Town View Foods comprise a trading loss of £158,479 in the period under review, together with accruals for trading losses in July and August, expenses provided for on the sale and the aforementioned good will write off.

 

 

Outlook

The aforementioned divestments will greatly simplify Roebuck Food group, resulting in a reduced overhead and with a balance sheet with a small net debt of circa £0.1m.

 

Management are excited for the prospects of the group. We are seeing good opportunities to grow the business in areas where we have capability and competence and look forward to delivering for shareholders in the months ahead.

 

 

Dividend

The board does not recommend the payment of a dividend.

 

Roebuck Food Group Plc

 

 

 

 

 

Consolidated income statement

 

For the six months ended 30 June 2024

 

 

 

Six months

Six months

 

ended

ended

 

30 June

30 June

 

2024

2023

 

(Unaudited)

(Restated)

 

 

 

£'000

£'000

 

 

 

Continuing operations

 

 

Revenue

 

5,966

1,664

Cost of sales

 

(5,688)

(1,601)

Gross profit

 

278

63

 

 

Administrative expenses

 

(564)

(397)

Acquisition and related costs

 

(35)

-

 

Operating loss from continuing operations

 

(321)

(334)

 

 

 

Finance income - interest receivable

 

3

-

Finance expenses - lease interest

 

-

-

Finance expenses - interest on bank loans

 

(7)

(3)

Loss on continuing activities before taxation

 

(325)

(337)

 

 

Income taxes - Corporation tax

 

-

-

Income taxes - Deferred tax

 

-

-

 

 

Loss for the period attributable to owners of the parent from continuing operations

 

(325)

(337)

 

 

Loss from discontinued activities

 

(3,753)

(197)

 

 

Loss for the period

 

(4,078)

(534)

 

 

Other comprehensive income

 

(11)

(100)

 

 

Total comprehensive income for the year

 

(4,089)

(634)

 

Earnings per share expressed in pence per share:

 

 

From continuing operations

- basic

 

(0.65)p

(0.67)p

- diluted

 

(0.65)p

(0.67)p

From discontinued operations

- basic

 

(7.5)p

(0.39)p

- diluted

 

(7.5)p

(0.39)p

 

 

 

 

 

 

 

 

Roebuck Food Group plc

 

 

Financial position

 

 

As at 30 June 2024

 

 

 

As at

As at

As at

 

30 June

30 June

31 December

 

2024

2023

2023

 

(Unaudited)

(Unaudited)

(Audited)

 

 

 

£'000

£'000

£'000

 

ASSETS

 

 

Non-current assets

 

 

Goodwill

-

2,338

2,338

 

Biological assets

-

1,015

642

 

Intangible assets

570

-

600

 

Property, plant and equipment

1,091

2,024

3,048

 

1,661

5,377

6,628

 

Current assets

 

 

 

Trade and other receivables

1,645

4,747

3,649

 

Inventories

1,061

794

1,044

 

Assets held for sale

4,274

-

-

 

Cash and cash equivalents

51

1,055

1,186

 

7,031

6,596

5,879

 

 

 

 

 

TOTAL ASSETS

8,692

11,973

12,507

 

 

 

 

 

Equity attributable to equity holders of the parent

And non-controlling interest

 

 

 

Share capital

990

564

990

 

Share premium account

2,094

-

2,094

 

Other reserves

(105)

(168)

(94)

 

Retained earnings

(725)

4,670

3,353

 

TOTAL EQUITY

2,254

5,066

6,343

 

 

Non-current liabilities

 

 

 

Borrowings

28

943

932

 

Deferred tax

72

58

168

 

 

100

1,001

1,100

 

 

 

 

 

 

Current liabilities

 

 

 

Trade and other payables

1,770

3,356

3,826

 

Liabilities held for sale

4,405

154

-

 

Borrowings

163

2,396

1,238

 

6,338

5,906

5,064

 

 

 

 

TOTAL EQUITY AND LIABILITIES

8,692

11,973

12,507

 

 

 

 

 

 

 

 

 

 

Roebuck Food Group plc

Consolidated statement of changes in equity

For the six months ended 30 June 2024

 

 

 

 

 

 

 

 

 

 

 

Share

Share

Other

Other

Distributable

Retained

 

 

 

 

 

capital

premium

Reserves

Reserves

earnings

Total

 

 

 

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

At 1 January 2023

564

-

(68)

-

5,204

5,700

 

 

 

 

Profit for the financial year

-

-

-

-

(534)

(534)

 

Foreign exchange gain

-

-

(100)

-

-

(100)

 

Total comprehensive income for the period

-

-

(100)

-

(534)

(634)

 

 

 

Issue of share capital

-

-

-

-

-

-

 

Equity dividends paid (recognised directly in equity)

-

-

-

-

-

-

 

Transactions with owners

-

-

(100)

-

(534)

(634)

 

 

 

At 30 June 2023

564

-

(168)

-

4,670

5,066

 

 

 

 

 

 

 

 

 

 

 

 

 

Net profit for the financial period

-

-

-

-

(1,317)

(1,317)

 

Foreign exchange loss

-

-

74

-

-

74

 

Total comprehensive income for the period

-

-

74

-

(1,317)

(1,243)

 

 

 

Issue of share capital

426

2,224

-

-

-

2,650

 

Share issue costs

-

(130)

-

-

-

(130)

 

Transactions with owners

426

2,094

74

-

(1,317)

1,277

 

 

 

At 31 December 2023

990

2,094

(94)

 

-

3,353

6,343

 

 

 

 

Net profit for the financial period

-

-

-

-

(4,078)

(4,078)

Foreign Exchange Gain

-

-

(11)

-

-

(11)

Total comprehensive income for the period

-

-

(11)

-

(4,078)

(4,089)

 

 

Issue of share capital

-

-

-

-

-

-

Equity dividends paid (recognised directly in equity)

-

-

-

-

-

-

Transactions with owners

-

-

(11)

-

(4,078)

(4,089)

 

 

At 30 June 2024

990

2,094

(105)

 

-

(725)

2,254

 

 

 

 

 

 

 

Roebuck Food Group plc

 

 

 

Consolidated cash flow statement

 

For the six months ended 30 June 2024

 

 

Six months

Six months

Ended

ended

30 June

30 June

2024

2023

(Unaudited)

(Restated)

£'000

£'000

Loss on continuing activities before taxation

(325)

(337)

Gain on biological assets

-

(160)

Loss on sale of biological assets

-

-

Foreign exchange loss/(gain)

-

100

Loss on discontinued activities

(3,753)

(197)

Finance expenses

7

81

Finance income

(3)

(13)

Bad debt expenses

-

25

Taxation charge

-

-

Impairment - Intangible Asset

30

-

Impairment - Goodwill

2,338

-

Depreciation - property, plant and equipment

33

84

(1,673)

(417)

Changes in working capital:

 

Increase in inventories

(145)

(478)

(Increase)/decrease in trade and other receivables

(246)

2,476

Decrease in trade and other receivables for disposal

-

-

Increase in current assets held for sale

(4,274)

-

Decrease/(increase) in current liabilities held for sale

4,405

144

Increase/(decrease) in payables

(37)

(71)

Taxation paid

-

-

Net cash (used)/ generated from operating activities

(297)

2,071

 

Investing activities

 

Proceeds of biological assets

-

15

Proceeds from Sale of farming division

1,192

-

Payments to acquire subsidiary undertaking

-

-

Cash acquired as part of acquisition

-

-

Purchase of property, plant and equipment

(17)

(28)

Net cash used in investing activities

1,175

(13)

 

Financing activities

 

Invoice finance

(328)

(1,973)

Finance lease capital repayments

(12)

(91)

Finance lease advance

-

-

Net proceeds from issue of share capital

-

-

Term loan repayments

-

(13)

Net cash used in financing activities

(340)

(2,077)

 

 

Net decrease in cash and cash equivalents

(1,135)

(436)

 

Cash and cash equivalents, at beginning of period

1,186

1,491

Cash and cash equivalents end of period

51

1,055

 

Note: The accounting policies applied throughout the period are consistent with those applied for the year ended 31 December 2023, as set out in the 2023 Annual Report.

 

 

 

Enquiries:

Roebuck Food Group

Aidan Hughes, Finance Director

Telephone: + 44 1293 862 498

 

Davy (Nomad)

Anthony Farrell

Telephone: + 353 1 679 6363

 

 

 

 

 

 

 

 

 

 

 

Six months

Year

 

ended

Ended

 

30 June

31 December

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR PPUAPBUPCGRQ
Date   Source Headline
2nd Jun 202611:10 amRNSShareholding Clarification
2nd Jun 20267:00 amRNSChange of Nominated Adviser
28th May 202611:32 amRNSResult of AGM
5th May 20263:35 pmRNSAnnual Report 2025 and Notice of AGM 2026
29th Apr 20262:44 pmRNSPreliminary Results
27th Jan 20267:00 amRNSTrading Update
30th Sep 202512:00 pmRNSInterim Results 2025
30th May 20255:30 pmRNSResult of AGM
2nd May 20259:00 amRNSAnnual Report 2024 and Notice of AGM 2025
28th Mar 20257:00 amRNSPreliminary Results
25th Feb 20252:00 pmRNSAppointment of Non-Executive Director and Chairman
7th Feb 20256:08 pmRNSCompletion of Investment
28th Jan 20255:45 pmRNSHolding(s) in Company
23rd Jan 20253:19 pmRNSResult of Extraordinary General Meeting
2nd Jan 20257:00 amRNSDate of Upcoming EGM
23rd Dec 20242:54 pmRNSPosting of Circular with Notice of EGM
20th Dec 20246:26 pmRNSResult of Placing and Subscription
20th Dec 202412:00 pmRNSProposed co-Investor and Fundraise Update
13th Dec 20246:14 pmRNSProposed Investment and Fundraising
22nd Nov 20247:00 amRNSNotification of substantial shareholding
21st Oct 20243:00 pmRNSChairman Ted O’Neill
27th Sep 20247:00 amRNSInterim Results 2024
6th Sep 20242:15 pmRNSDisposal of Animal Protein Division
29th Aug 20249:45 amRNSResult of Extraordinary General Meeting
9th Aug 20242:50 pmRNSPosting of Circular with Notice of EGM
1st Aug 20247:00 amRNSProposed disposal of Animal Protein Division
5th Jul 20245:10 pmRNSHolding(s) in Company
5th Jul 20245:00 pmRNSHolding(s) in Company
30th May 20243:30 pmRNSResult of AGM
29th May 20245:20 pmRNSDisposal of Dairy Division
14th May 20245:50 pmRNSNotice of AGM
30th Apr 20244:30 pmRNS2023 Annual Report
28th Mar 202410:20 amRNSCHAIRMAN'S STATEMENT - FINAL RESULTS
11th Jan 20244:50 pmRNSContinuance in Office of Director
4th Dec 20236:18 pmRNSIssue of Consideration Shares
30th Nov 20233:04 pmRNSResults of Extraordinary General Meeting
6th Nov 20235:10 pmRNSPlacing and Related Subscription Update
6th Nov 20232:00 pmRNSPosting of Circular with Notice of EGM
3rd Nov 20236:28 pmRNSResult of Placing and related Subscription
3rd Nov 20237:05 amRNSProposed Acquisition and Launch of Placing
29th Sep 20237:00 amRNSInterim results 2023
29th Sep 20237:00 amRNSResult of AGM
29th Aug 20234:28 pmRNSNotice of AGM
5th Jul 20237:00 amRNSManagement and Directorate Changes
28th Apr 20235:30 pmRNS2022 Annual Report
14th Apr 202310:00 amRNSDirectorate Change
31st Mar 20232:13 pmRNSChairman's Statement - Final Results
3rd Mar 20235:45 pmRNSExecutive Director Bonus
30th Dec 20227:00 amRNSDeputy Chairman
17th Nov 20225:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.